Innovation, M&A, and Value: Why Biotech Deserves a Fresh Look in Your Portfolio

Few sectors of the market capture the imagination- or the headlines- like biotech. From blockbuster drug breakthroughs to headline-making FDA approvals, the biotechnology sector offers some of the highest risk-reward potential of any industry.

However, today, biotechnology stocks are more than just a speculative investment.

They’re quickly becoming core components of growth-oriented portfolios fueled by aging populations, scientific advancements, and an increasing pace of innovation. Currently, thanks to the headlines, they offer a compelling value.

For investors willing to dig into the science, biotech can be a powerful engine for portfolio returns. One that can also serve as a powerful income play.